2024
A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States
Poghosyan H, Sarkar S, Richman I, Pietrzak R, Carter-Bawa L, Cooley M. A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States. JTO Clinical And Research Reports 2024, 5: 100705. PMID: 39282662, PMCID: PMC11402037, DOI: 10.1016/j.jtocrr.2024.100705.Peer-Reviewed Original ResearchLung cancer screeningLung cancer screening utilizationScreening utilizationBehavioral Risk Factor Surveillance SystemRates of lung cancer screeningRisk Factor Surveillance SystemScreening-eligible individualsCancer screening utilizationLung cancer burdenPopulation-based dataMultivariate logistic regressionCancer screeningCancer burdenImpact healthcareNational ratesIncreased oddsLogistic regressionNationwide effortSurveillance systemCOVID-19COVID-19 pandemicLung diseaseBrief reportNo sex differencesUnited StatesACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update
Imaging P, Niell B, Jochelson M, Amir T, Brown A, Adamson M, Baron P, Bennett D, Chetlen A, Dayaratna S, Freer P, Ivansco L, Klein K, Malak S, Mehta T, Moy L, Neal C, Newell M, Richman I, Schonberg M, Small W, Ulaner G, Slanetz P. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update. Journal Of The American College Of Radiology 2024, 21: s126-s143. PMID: 38823941, DOI: 10.1016/j.jacr.2024.02.019.Peer-Reviewed Original ResearchConceptsReduce breast cancer mortalityRecommendation of mammographyBreast cancerBreast cancer mortalityBreast cancer riskBreast cancer screeningDigital breast tomosynthesisEvidence-based guidelinesAmerican College of Radiology Appropriateness CriteriaPeer-reviewed journalsMultidisciplinary expert panelRAND/UCLA Appropriateness Method User ManualMultiple different imaging modalitiesPeer-reviewed literatureScreening recommendationsCancer screeningCancer mortalityCancer riskGuideline developmentAppropriateness of imagingRecommendations AssessmentBreast tomosynthesisEstablished methodology principlesExpert panelAmerican CollegeLung cancer screening use among screening‐eligible adults with disabilities
Poghosyan H, Richman I, Sarkar S, Presley C. Lung cancer screening use among screening‐eligible adults with disabilities. Journal Of The American Geriatrics Society 2024, 72: 1155-1165. PMID: 38357789, PMCID: PMC11018473, DOI: 10.1111/jgs.18795.Peer-Reviewed Original ResearchLung cancer screeningDisability countSelf-careDisability typeHarms of lung cancer screeningUS Preventive Services Task Force criteriaLung Cancer Screening ModuleLung cancer screening utilizationBehavioral Risk Factor Surveillance SystemRates of lung cancer screeningRisk Factor Surveillance SystemCancer screening useScreening-eligible adultsIndependent livingLack of clinical guidelinesTobacco use historyCognitive impairmentTask Force criteriaCross-sectional dataCancer screeningMultivariate logistic regression analysisLogistic regression analysisScreen useNo cognitive impairmentPack-yearsDigital Interventions to Support Lung Cancer Screening: A Systematic Review
Odole I, Andersen M, Richman I. Digital Interventions to Support Lung Cancer Screening: A Systematic Review. American Journal Of Preventive Medicine 2024, 66: 899-908. PMID: 38246408, PMCID: PMC11451259, DOI: 10.1016/j.amepre.2024.01.007.Peer-Reviewed Original ResearchLung cancer screeningMulti-level interventionsJoanna Briggs InstituteDigital interventionsLow-dose computed tomographyDecision aidCancer screeningElectronic health record (EHR)-based interventionsUptake of lung cancer screeningPromote lung cancer screeningEffectiveness of digital interventionsSystematic review INTRODUCTIONImprove knowledgeDiverse healthcare settingsReduce decisional conflictLung cancer mortalityEvaluate implementation strategiesRelated to knowledgeScreening behaviorEngaging patientsDecisional conflictAppraisal ToolCancer mortalityScreen useHealthcare settings
2023
Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
Richman I, Long J, Soulos P, Wang S, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2023, 176: 1172-1180. PMID: 37549389, PMCID: PMC10623662, DOI: 10.7326/m23-0133.Peer-Reviewed Original ResearchConceptsCumulative incidenceBreast cancerBreast cancer screeningUnscreened womenOlder womenCancer screeningBreast cancer-specific deathBreast cancer overdiagnosisService Medicare claimsRetrospective cohort studyCancer-specific deathBreast cancer deathsWomen 70 yearsHarms of overdiagnosisNational Cancer InstituteBreast cancer diagnosisCohort studyCancer overdiagnosisCancer deathSEER programMedicare claimsCancer InstituteOverdiagnosisGreater incidenceCancerCancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study
Aminawung J, Soulos P, Oladeru O, Lin H, Gonsalves L, Puglisi L, Hassan S, Richman I, Wang E, Gross C. Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study. Cancer Medicine 2023, 12: 15447-15454. PMID: 37248772, PMCID: PMC10417084, DOI: 10.1002/cam4.6162.Peer-Reviewed Original ResearchConceptsNon-Hispanic Black individualsScreen-detectable cancersStandardized incidence ratiosNon-Hispanic white individualsCancer incidenceGeneral populationStatewide retrospective cohort studyRetrospective cohort studyWhite individualsState tumor registryLower cancer incidenceBlack individualsHigher cancer incidenceIncarceration exposureCohort studyRetrospective cohortTumor RegistryIncidence ratiosIncarcerated individualsCancer screeningIncidence rateHigh incidenceConnecticut residentsEthnic strataIncidence
2022
The role of lung cancer risk and comorbidity in lung cancer screening use
Richman IB, Long JB, Poghosyan H, Sather P, Gross CP. The role of lung cancer risk and comorbidity in lung cancer screening use. Preventive Medicine Reports 2022, 30: 102006. PMID: 36203942, PMCID: PMC9530957, DOI: 10.1016/j.pmedr.2022.102006.Peer-Reviewed Original ResearchLung cancer screeningLung cancer riskDiagnostic chest CTCancer riskLow comorbidityCancer screeningChest CTGreater lung cancer riskHigher lung cancer riskLow-dose computed tomographyCancer screening useLung cancer mortalityDose computed tomographyElectronic health recordsLCS useCohort studyPatient characteristicsEligible adultsCancer mortalityScreening useComorbiditiesComputed tomographyDiagnostic CTDiagnostic imagingPatientsBreast cancer screening during the COVID-19 pandemic: moving from disparities to health equity
Richman I, Tessier-Sherman B, Galusha D, Oladele CR, Wang K. Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity. Journal Of The National Cancer Institute 2022, 115: 139-145. PMID: 36069622, PMCID: PMC9494402, DOI: 10.1093/jnci/djac172.Peer-Reviewed Original ResearchConceptsBreast cancer screeningCancer screeningHealth systemHealth equityBreast cancer controlRoutine health careCOVID-19 pandemicCOVID-19 waveMammography ratesCancer controlMammography useMultifactorial conditionHealth disparitiesWhite womenScreening mammographyHealth careWomenCOVID-19Subsequent COVID-19 wavesLower ratesNumber of studiesMammographyDisparitiesPandemicSpecific patternsLost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening
Richman IB, Prasad TV, Gross CP. Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening. Preventive Medicine Reports 2022, 29: 101909. PMID: 35911579, PMCID: PMC9326340, DOI: 10.1016/j.pmedr.2022.101909.Peer-Reviewed Original ResearchLung cancer screeningCancer screeningSafety-net primary care practicesPrimary care practicesEligible adultsLung cancerLack of knowledgeHigh riskNational guidelinesPatientsCare practicesScreeningImportant barriersAdultsSmall proportionQualitative studyImportant populationSemi-structured interviewsParticipantsCancerMonths
2021
Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old
Richman IB, Long JB, Hoag JR, Upneja A, Hooley R, Xu X, Kunst N, Aminawung JA, Kyanko KA, Busch SH, Gross CP. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old. Journal Of The National Cancer Institute 2021, 113: 1515-1522. PMID: 33822120, PMCID: PMC8757313, DOI: 10.1093/jnci/djab063.Peer-Reviewed Original ResearchConceptsHigher cancer detection rateCancer detection rateBreast cancer screeningCancer screeningScreening outcomesBreast cancer screening outcomesDigital breast tomosynthesisCancer screening outcomesPopulation-level adoptionReal-world cohortMultivariable logistic regressionHigher biopsy ratesPatient-level analysisPopulation health impactDetection rateIncident cancerClinical outcomesWomen 40Biopsy rateObservational studyComparative effectivenessLogistic regressionYoung womenPrivate health insurersWomen
2020
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.Peer-Reviewed Original Research
2019
Adoption of Digital Breast Tomosynthesis in Clinical Practice
Richman IB, Hoag JR, Xu X, Forman HP, Hooley R, Busch SH, Gross CP. Adoption of Digital Breast Tomosynthesis in Clinical Practice. JAMA Internal Medicine 2019, 179: 1292-1295. PMID: 31233086, PMCID: PMC6593646, DOI: 10.1001/jamainternmed.2019.1058.Peer-Reviewed Original Research